Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography

Journal of the American College of Cardiology

Volumn 30, Issue 3, 1997, Pages 595-606

  Geleijnse, Marcel L ^a   Fioretti, Paolo M ^a   Roelandt, Jos R T C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; EXERCISE TEST; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVIEW;

CORONARY DISEASE; DOBUTAMINE; ECHOCARDIOGRAPHY; EXERCISE TEST; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; OBSERVER VARIATION; SENSITIVITY AND SPECIFICITY;

EID: 0030884991     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00206-4     Document Type: Review

References (103)

1. Morbidity from Coronary Heart Disease in the United States: National Heart, Lung, and Blood Institute Data Fact Sheet. Bethesda (MD): National Heart, Lung, and Blood Institute, 1990.
2. Chaitman BR. The changing role of the exercise electrocardiogram as a diagnostic and prognostic test for chronic ischemic heart disease. J Am Coll Cardiol. 8:1986;1195-1210.
3. Marwick T. Current status of non-invasive techniques for the diagnosis of myocardial ischemia. Acta Clin Belg. 47:1992;1-5.
4. Berthe C, Piérard LA, Hiernaux M, et al. Predicting the extent and location of coronary artery disease in acute myocardial infarction by echocardiography during dobutamine infusion. Am J Cardiol. 58:1986;1167-1172.
5. Sawada SG, Segar DS, Ryan T, et al. Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation. 83:1991;1605-1614.
6. Previtali M, Lanzarini L, Ferrario M, Tortorici M, Mussini A, Montemartini C. Dobutamine versus dipyridamole in coronary artery disease. Circulation. (Suppl III):1991;III-27-III-31.
7. Cohen JL, Greene TO, Ottenweller J, Binenbaum SZ, Wilchfort SD, Kim CS. Dobutamine digital echocardiography for detecting coronary artery disease. Am J Cardiol. 67:1991;1311-1318.
8. Salustri A, Fioretti PM, Pozzoli MMA, McNeill AJ, Roelandt JRTC. Dobutamine stress echocardiography its role in the diagnosis of coronary artery disease . Eur Heart J. 13:1992;70-77.
9. Martin TW, Seaworth JF, Johns JP, Pupa LE, Condos WR. Comparison of adenosine, dipyridamole, and dobutamine in stress echocardiography. Ann Intern Med. 116:1992;190-196.
10. Segar DS, Brown SE, Sawada SG, Ryan T, Feigenbaum H. Dobutamine stress echocardiography correlation with coronary lesion severity as determined by quantitative angiography . J Am Coll Cardiol. 19:1992;1197-1202.
11. Marcovitz PA, Armstrong WF. Accuracy of dobutamine stress echocardiography in detecting coronary artery disease. Am J Cardiol. 69:1992;1269-1273.
12. Mazeika PK, Nadazdin A, Oakley CM. Dobutamine stress echocardiography for detection and assessment of coronary artery disease. J Am Coll Cardiol. 19:1992;1203-1211.
13. Salustri A, Fioretti PM, McNeill AJ, Pozzoli MMA, Roelandt JRTC. Pharmacological stress echocardiography in the diagnosis of coronary artery disease and myocardial ischemia a comparison between dobutamine and dipyridamole . Eur Heart J. 13:1992;1356-1362.
14. McNeill AJ, Fioretti PM, El-Said EM, Salustri A, Forster T, Roelandt JRTC. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol. 70:1992;41-46.
15. Marwick T, Willemart B, D'Hondt AM, et al. Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion comparison of dobutamine and adenosine using echocardiography and 99m Tc-MIBI single photon emission computed tomography . Circulation. 87:1993;345-354.
16. Günalp B, Dokumaci B, Uyan C, et al. Value of dobutamine technetium-99m-sestamibi SPECT and echocardiography in the detection of coronary artery disease compared with coronary angiography. J Nucl Med. 34:1993;889-894.
17. Forster T, McNeill AJ, Salustri A, et al. Simultaneous dobutamine stress echocardiography and 99m-technetium isonitrile single-photon emission computed tomography in patients with suspected coronary artery disease. J Am Coll Cardiol. 21:1993;1591-1596.
18. Marwick T, D'Hondt AM, Baudhuin T, et al. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease combination with echocardiography or scintigraphy, or both? J Am Coll Cardiol. 22:1993;159-167.
19. Hoffmann R, Lethen H, Kleinhans E, Weiss M, Flachskampf FA, Hanrath P. Comparative evaluation of bicycle and dobutamine stress echocardiography with perfusion scintigraphy and bicycle electrocardiogram for identification of coronary artery disease. Am J Cardiol. 72:1993;555-559.
20. Previtali M, Lanzarini L, Fetiveau R, et al. Comparison of dobutamine stress echocardiography, dipyridamole stress echocardiography and exercise stress testing for diagnosis of coronary artery disease. Am J Cardiol. 72:1993;865-870.
21. Takeuchi M, Araki M, Nakashima Y, Kuroiwa A. Comparison of dobutamine stress echocardiography and stress thallium-201 single-photon emission computed tomography for detecting coronary artery disease. J Am Soc Echocardiogr. 6:1993;593-602.
22. Baudhuin T, Marwick T, Melin J, Wijns W, D'Hondt AM, Detry JM. Diagnosis of coronary artery disease in elderly patients safety and efficacy of dobutamine echocardiography . Eur Heart J. 14:1993;799-803.
23. Cohen JL, Ottenweller JE, George AK, Duvvuri S. Comparison of dobutamine and exercise echocardiography for detecting coronary artery disease. Am J Cardiol. 72:1993;1226-1231.
24. Marwick TH, D'Hondt AM, Mairesse GH, et al. Comparative ability of dobutamine and exercise stress in inducing myocardial ischemia in active patients. Br Heart J. 72:1994;31-38.
25. Beleslin BD, Ostojic M, Stepanovic J, et al. Stress echocardiography in the detection of myocardial ischemia head-to-head comparison of exercise, dobutamine, and dipyridamole tests . Circulation. 90:1994;1168-1176.
26. Senior R, Sridhara BS, Anagnostou E, Handler C, Raftery EB, Lahiri A. Synergistic value of simultaneous stress dobutamine sestamibi single-photon-emission computerized tomography and echocardiography in the detection of coronary artery disease. Am Heart J. 128:1994;713-718.
27. Sochowski RA, Yvorchuk KJ, Yang YY, Rattes MF, Chan KL. Dobutamine and dipyridamole stress echocardiography in patients with a low incidence of severe coronary artery disease. J Am Soc Echocardiogr. 8:1995;482-487.
28. Ostojic M, Picano E, Beleslin B, et al. Dipyridamole-dobutamine echocardiography a novel test for the detection of milder forms of coronary artery disease . J Am Coll Cardiol. 23:1994;1115-1122.
29. Daoud EG, Pitt A, Armstrong WF. Electrocardiographic response during dobutamine stress echocardiography. Am Heart J. 129:1995;672-677.
30. Dagianti A, Penco M, Agati L, et al. Stress echocardiography comparison of exercise, dipyridamole and dobutamine in detecting and predicting the extent of coronary artery disease . J Am Coll Cardiol. 26:1995;18-25.
31. Ho FM, Huang PJ, Liau CS, et al. Dobutamine stress echocardiography compared with dipyridamole thallium-201 single-photon emission computed tomography in detecting coronary artery disease. Eur Heart J. 16:1995;570-575.
32. Pingitore A, Picano E, Quarta Colosso M, et al. The atropine factor in pharmacologic stress echocardiography. J Am Coll Cardiol. 27:1996;1164-1170.
33. Rozanski A. Assessment of the information boondoggle resulting from the evaluation of noninvasive tests in cardiology. J Nucl Med. 36:1995;1009-1013.
34. Ruffolo RR. The pharmacology of dobutamine. Am J Med. 294:1987;244-248.
35. Meyer SL, Curry GC, Donsey MS, Twieg DB, Parkey RW, Willerson JT. Influence of dobutamine on hemodynamics and coronary blood flow in patients with and without coronary artery disease. Am J Cardiol. 38:1976;103-108.
36. Fung AY, Gallagher KP, Buda AJ. The physiologic basis of dobutamine as compared with dipyridamole stress interventions in the assessment of critical coronary stenosis. Circulation. 76:1987;943-951.
37. Pellikka PA, Roger VL, Oh JK, Miller FA, Seward JB, Tajik J. Stress echocardiography part II. Dobutamine stress echocardiography techniques, implementation, clinical applications, and correlations . Mayo Clin Proc. 70:1995;16-27.
38. Williams ME, Gervino EV, Rosa RM, et al. Catecholamine modulation of rapid potassium shifts during exercise. N Engl J Med. 312:1985;823-827.
39. Coma-Canella I. Changes in plasma potassium during the dobutamine stress test. Int J Cardiol. 33:1991;55-60.
40. Recommendations of quantification of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr. 2:1989;358-367.
41. Castini D, Gentile F, Ornaghi M, et al. Dobutamine echocardiography usefulness of digital image processing . Eur Heart J. 16:1995;1420-1424.
42. Senior R, Lahiri A. Enhanced detection of myocardial ischemia by stress dobutamine echocardiography utilizing the "biphasic" response of wall thickening during low and high dose dobutamine infusion. J Am Coll Cardiol. 26:1995;26-32.
43. Carstensen S, Ali SM, Stensgaard-Hansen FV, et al. Dobutamine-atropine stress echocardiography in asymptomatic healthy individuals the relativity of stress-induced hyperkinesia . Circulation. 92:1995;3453-3463.
44. Bach DS, Muller DWM, Gros BJ, Armstrong WF. False positive dobutamine stress echocardiograms characterization of clinical, echocardiographic and angiographic findings . J Am Coll Cardiol. 24:1994;928-933.
45. Labovitz AJ, Lewen MK, Kern M, Vandormael M, Deligonal U, Kennedy HL. Evaluation of left ventricular systolic and diastolic dysfunction during transient myocardial ischemia produced by angioplasty. J Am Coll Cardiol. 10:1987;748-755.
46. Nishimura RA, Abel MD, Hatle LK, Tajik AJ. Assessment of diastolic function of the heart background and current applications of Doppler echocardiography. Part II. Clinical studies . Mayo Clin Proc. 64:1989;181-204.
47. El-Said EM, Roelandt JRTC, Fioretti PM, et al. Abnormal left ventricular early diastolic filling during dobutamine stress Doppler echocardiography is a sensitive indicator of significant coronary artery disease. J Am Coll Cardiol. 24:1994;1618-1624.
48. Hopfenspirger MR, Miller TD, Christian TF, Gibbons RJ. Sinus node deceleration during dobutamine perfusion scintigraphy as a marker of inferior ischemia. Am J Cardiol. 74:1994;817-819.
49. Miller TD, Gibbons RJ, Squires RW, Allison TG, Gau GT. Sinus node deceleration during exercise as a marker of significant narrowing of the right coronary artery. Am J Cardiol. 71:1993;371-372.
50. Mazeika PK, Nadazdin A, Oakley CM. Clinical significance of abrupt vasodepression during dobutamine stress echocardiography. Am J Cardiol. 69:1992;1484-1486.
51. Heinle KH, Tice FD, Kisslo J. Effect of dobutamine stress echocardiography on mitral regurgitation. J Am Coll Cardiol. 25:1995;122-127.
52. Keren G, Katz S, Strom J, Sonnenblick EH, Lejemtel TH. Dynamic mitral regurgitation an important determinant of the hemodynamic response to load alterations and inotropic therapy in severe heart failure . Circulation. 80:1989;306-313.
53. Tanimoto M, Pai RG, Jintapakorn W. Normal changes in left ventricular filling and hemodynamics during dobutamine stress echocardiography. J Am Soc Echocardiogr. 8:1995;488-493.
54. Tanimoto M, Pai RG, Jintapakorn W, Shah PM. Mechanism of hypotension during dobutamine stress echocardiography in patients with coronary artery disease. Am J Cardiol. 76:1995;26-30.
55. Pellikka PA, Oh JK, Bailey KR, Nichols BA, Monahan KH, Tajik JA. Dynamic intraventricular obstruction during dobutamine stress echocardiography a new observation . Circulation. 86:1992;1429-1432.
56. Heinle SK, Tice FD, Kisslo J. Hypotension during stress echocardiography is it related to dynamic intraventricular obstruction? Am Heart J. 130:1995;314-317.
57. Rosamond TL, Vacek JL, Hurwitz A, Rowland AJ, Beauchamp GD, Crouse LJ. Hypotension during dobutamine stress echocardiography initial description and clinical relevance . Am Heart J. 123:1992;403-407.
58. Weissman NJ, Nidorf SM, Weyman AE, Picard MH. Effect of hydration on cavity obliteration during dobutamine stress echocardiography. Clin Cardiol. 18:1995;17-20.
59. Mark AL. The Bezold-Jarisch reflex revisited clinical implications of inhibitory reflexes originating in the heart . J Am Coll Cardiol. 11:1983;90-102.
60. Dubach P, Froelicher VF, Klein J, Oakes D, Grover-Mckay M, Friis R. Exercise-induced hypotension in a male population criteria, causes and prognosis . Circulation. 78:1988;1380-1387.
61. Marcovitz PA, Bach DS, Mathias W, Shayana V, Armstrong WF. Paradoxic hypotension during dobutamine stress echocardiography clinical and diagnostic implications . J Am Coll Cardiol. 21:1993;1080-1086.
62. Lieberman EB, Heinle SK, Wildermann N, Waugh RA, Kisslo JA, Bashore TM. Does hypotension during dobutamine stress echocardiography correlate with anatomic or functional cardiac impairment? Am Heart J. 129:1995;1121-1126.
63. Coma-Canella I. Dobutamine stress test to diagnose the presence and severity of coronary artery lesions in angina. Eur Heart J. 12:1991;1198-1204.
64. Mairesse GH, Marwick TH, Vanoverschelde JLJ, et al. How accurate is dobutamine stress electrocardiography for detection of coronary artery disease? J Am Coll Cardiol. 24:1994;920-927.
65. Gallik DM, Mahmarian JJ, Verani MS. Therapeutic significance of exercise-induced ST-segment elevation in patients without previous myocardial infarction. Am J Cardiol. 72:1993;1-7.
66. Previtali M, Lanzarini L, Mussini A, Ferrario M, Angoli L, Specchia G. Dobutamine-induced ST segment elevation in a patient with angina at rest and critical coronary lesions. Eur Heart J. 13:1992;997-999.
67. Elhendy A, Geleijnse ML, Roelandt JRTC, et al. Evaluation by quantitative 99m-technetium MIBI SPECT and echocardiography of myocardial perfusion and wall motion abnormalities in patients with dobutamine-induced ST-segment elevation. Am J Cardiol. 76:1995;441-448.
68. Poldermans D, Fioretti PM, Boersma E, et al. Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease experience in 650 consecutive examinations . Am J Cardiol. 73:1994;456-459.
69. Picano E, Mathias W Jr, Pingitore R, Bigi R, Previtali M. Safety and tolerability of dobutamine-atropine stress echocardiography a prospective, multicentre study . Lancet. 344:1994;1190-1192.
70. Mertes H, Sawada SG, Ryan T, et al. Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography experience in 1118 patients . Circulation. 88:1993;15-19.
71. Geleijnse ML, Elhendy A, Van Domburg RT, et al. Prognostic significance of systolic blood pressure changes during dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain and known or suspected coronary artery disease. Am J Cardiol. 79:1997;1031-1035.
72. Brown JH, Taylor P. Muscarinic receptor agonists and antagonists. Hardman JG, Limbird LE. The Pharmacological Basis of Therapeutics. 1996;141-160 McGraw-Hill, New York.
73. Hoffmann R, Lethen H, Marwick TH, et al. Analysis of interinstitutional observer agreement in interpretation of dobutamine stress echocardiograms. J Am Coll Cardiol. 27:1996;330-336.
74. Bach DS, Hepner A, Marcovitz PA, Armstrong WF. Dobutamine stress echocardiography prevalence of a nonischemic response in a low-risk population . Am Heart J. 125:1993;1257-1261.
75. Lieng LH, Pellikka PA, Mahoney DW, et al. Atropine augmentation in dobutamine stress echocardiography role and incremental value in a clinical practice setting . J Am Coll Cardiol. 28:1996;551-557.
76. Weissman NJ, Levangie MW, Newell JB, Guerrero LJ, Weyman AE, Picard MH. Effect of beta-adrenergic receptor blockade on the physiologic response to dobutamine stress echocardiography. Am Heart J. 130:1995;248-253.
77. Fioretti PM, Poldermans D, Salustri A, et al. Atropine increases the accuracy of dobutamine stress echocardiography in patients taking beta-blockers. Eur Heart J. 15:1994;355-360.
78. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary artery disease. N Engl J Med. 300:1979;1350-1358.
79. Geleijnse ML, Marwick TH, Boersma E, Deckers JW, Melin JA, Fioretti PM. Optimal pharmacological stress testing for the diagnosis of coronary artery disease a probabilistic approach . Eur Heart J. 16:(Suppl M):1995;3-10.
80. Califf RM, Harrell FE Jr, Lee KL, et al. The evolution of medical and surgical therapy for coronary artery disease a 15-year perspective . JAMA. 67:1989;302-309.
81. Panza JA, Curiel RV, Laurienzo JM, Quyyumi AA, Dilsizian V. Relation between ischemic threshold measured during dobutamine stress echocardiography and known indices of poor prognosis in patients with CAD. Circulation. 92:1995;2095-2101.
82. Olson CE, Porter TR, Deligonul U, Xie F, Anderson JR. Left ventricular volume changes during dobutamine stress echocardiography identify patients with more extensive coronary artery disease. J Am Coll Cardiol. 24:1994;1268-1273.
83. Orzan F, Garcia E, Mathur VS, Hall RJ. Is the treadmill exercise test useful for evaluating coronary artery disease in patients with complete left bundle branch block? Am J Cardiol. 42:1978;36-40.
84. Senior R, Basu S, Handler C, Raftery EB, Lahiri A. Diagnostic accuracy of dobutamine stress echocardiography for detection of coronary heart disease in hypertensive patients. Eur Heart J. 17:1996;289-295.
85. Hirzel HO, Senn M, Nuesch K, et al. Thallium-201 scintigraphy in complete left bundle branch block. Am J Cardiol. 53:1984;764-769.
86. Schulman DS, Francis DK, Black HR, Wackers FJ. Thallium-201 stress imaging in hypertensive patients. Hypertension. 10:1987;16-21.
87. Mairesse GH, Marwick TH, Arnese M, et al. Improved identification of coronary artery disease in patients with left bundle branch block by use of dobutamine stress echocardiography and comparison with myocardial perfusion tomography. Am J Cardiol. 76:1995;321-325.
88. Fitzgerald GA. Dipyridamole. N Engl J Med. 316:1987;1247-1257.
89. Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DD. Effects of adenosine on human coronary arterial circulation. Circulation. 82:1990;1595-1606.
90. Flameng W, Wunsten B, Schaper W. On the distribution of myocardial blood flow II. Effects of arterial stenosis and vasodilation . Basic Res Cardiol. 69:1974;435-446.
91. Demer L, Gould KL, Kirkeeide R. Assessing stenosis severity coronary flow reserve, collateral function, quantitative coronary arteriography, positron imaging, and digital subtraction angiography: a review and analysis . Prog Cardiovasc Dis. 30:1988;307-322.
92. Picano E, Pingitore A, Conti U, et al. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dipyridamole echocardiography. Eur Heart J. 14:1993;1216-1222.
93. Nesto RW, Kowalchuck GJ. The ischemic cascade temporal sequence of hemodynamic, electrocardiographic and symptomatic expressions of ischemia . Am J Cardiol. 57:1987;23C-27C.
94. Takeuchi M, Araki M, Nakashima Y, Kuroiwa A. The detection of residual ischemia and stenosis in patients with acute myocardial infarction with dobutamine stress echocardiography. J Am Soc Echocardiogr. 7:1994;242-252.
95. Bigi R, Occhi G, Fiorentini C, et al. Dobutamine stress echocardiography for the identification of multivessel coronary artery disease after uncomplicated myocardial infarction the importance of test end-point . Int J Cardiology. 50:1995;51-60.
96. Elhendy A, Van Domburg RT, Roelandt JRTC, et al. Accuracy of dobutamine stress echocardiography for the diagnosis of coronary artery stenosis in patients with myocardial infarction the impact of extent and severity of left ventricular dysfunction . Heart. 76:1996;123-128.
97. Elhendy A, Geleijnse ML, Roelandt JRTC, et al. Comparison of dobutamine stress echocardiography and 99m-technetium sestamibi SPECT myocardial perfusion scintigraphy for predicting extent of coronary artery disease in patients with healed myocardial infarction. Am J Cardiol. 79:1997;7-12.
98. Elhendy A, Cornel JH, Roelandt JRTC, et al. Relation between contractile response of akinetic segments during dobutamine stress echocardiography and myocardial ischemia assessed by simultaneous thallium-201 single-photon emission computed tomography. Am J Cardiol. 77:1996;955-959.
99. Smart SC, Knickelbine T, Stoiber TR, Carlos M, Wynsen JC, Sagar KB. Safety and accuracy of dobutamine-atropine stress echocardiography for the detection of residual stenosis of the infarct-related artery and multivessel disease during the first week after acute myocardial infarction. Circulation. 95:1997;1394-1401.
100. Marcovitz PA, Bach DS, Segar DS, Armstrong W. Impact of B-mode color encoding on rapid detection of ultrasound targets an in vitro study . J Am Soc Echocardiogr. 6:1993;382-386.
101. Crouse LJ, Cheirif J, Hanly DE, et al. Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography results of the Phase III Albunex multicenter trial . J Am Coll Cardiol. 22:1993;1494-1500.
102. Palka P, Lange A, Fleming AD, Sutherland GR, Fenn LN, McDicken NW. Doppler tissue imaging myocardial wall motion velocities in normal subjects . J Am Soc Echocardiogr. 8:1995;659-668.
103. Milunski MR, Mohr GA, Perez JE, et al. Ultrasonic tissue characterization with integrated backscatter acute myocardial ischemia, reperfusion, and stunned myocardium in patients . Circulation. 80:1989;491-503.